دورية أكاديمية
Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?
العنوان: | Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better? |
---|---|
المؤلفون: | Bendjelid K; Intensive Care Division, Geneva University Hospitals, Geneva, Switzerland; Geneva Haemodynamic Research Group, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland. Electronic address: karim.bendjelid@hcuge.ch., Giraud R; Intensive Care Division, Geneva University Hospitals, Geneva, Switzerland; Geneva Haemodynamic Research Group, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland., Von Düring S; Intensive Care Division, Geneva University Hospitals, Geneva, Switzerland; Geneva Haemodynamic Research Group, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland; Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. |
المصدر: | Anaesthesia, critical care & pain medicine [Anaesth Crit Care Pain Med] 2020 Aug; Vol. 39 (4), pp. 451-452. Date of Electronic Publication: 2020 Jul 09. |
نوع المنشور: | Editorial; Introductory Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Published by Elsevier Masson SAS on behalf of the Société française d'anesthésie et de réanimation (Sfar) Country of Publication: France NLM ID: 101652401 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-5568 (Electronic) Linking ISSN: 23525568 NLM ISO Abbreviation: Anaesth Crit Care Pain Med Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Issy-les-Moulineaux cedex, France : Published by Elsevier Masson SAS on behalf of the Société française d'anesthésie et de réanimation (Sfar), [2015]- |
مواضيع طبية MeSH: | Betacoronavirus*, Almitrine/*therapeutic use , Coronavirus Infections/*drug therapy , Hypoxia/*drug therapy , Pneumonia, Viral/*drug therapy , Respiratory Distress Syndrome/*drug therapy , Respiratory System Agents/*therapeutic use, Almitrine/administration & dosage ; COVID-19 ; Coronavirus Infections/complications ; Humans ; Hypoxia/etiology ; Pandemics ; Pneumonia, Viral/complications ; Respiratory Distress Syndrome/etiology ; Respiratory System Agents/administration & dosage ; SARS-CoV-2 |
References: | Crit Care. 2020 Jun 16;24(1):353. (PMID: 32546188) Am J Respir Crit Care Med. 2020 Jun 1;201(11):1319-1320. (PMID: 32281885) Intensive Care Med. 1994 May;20(5):379-89. (PMID: 7930036) Am J Respir Crit Care Med. 1999 Aug;160(2):473-9. (PMID: 10430716) Can J Anaesth. 1998 May;45(5 Pt 1):402-9. (PMID: 9598253) Eur Respir J. 1999 Dec;14(6):1244-5. (PMID: 10624749) Crit Care Med. 2001 Jan;29(1):32-6. (PMID: 11176154) Anaesth Crit Care Pain Med. 2020 Aug;39(4):471-472. (PMID: 32505755) Am J Respir Crit Care Med. 1998 Dec;158(6):1770-7. (PMID: 9847266) Anaesth Crit Care Pain Med. 2020 Jun;39(3):389-390. (PMID: 32305591) Anaesth Crit Care Pain Med. 2020 Aug;39(4):467-469. (PMID: 32505756) JAMA. 2020 Jun 9;323(22):2329-2330. (PMID: 32329799) Crit Care. 2001;5(2):67-71. (PMID: 11299064) Am J Respir Crit Care Med. 2020 May 15;201(10):1299-1300. (PMID: 32228035) Chest. 2020 Nov;158(5):2003-2006. (PMID: 32512007) Anesthesiology. 2015 Apr;122(4):932-46. (PMID: 25587641) Intensive Care Med. 1997 Sep;23(9):1008. (PMID: 9347377) |
فهرسة مساهمة: | Keywords: Almitrine; COVID-19; Capillary shunt; Hypoxemia |
المشرفين على المادة: | 0 (Respiratory System Agents) 9A1222NBG4 (Almitrine) |
تواريخ الأحداث: | Date Created: 20200713 Date Completed: 20200902 Latest Revision: 20210110 |
رمز التحديث: | 20221213 |
مُعرف محوري في PubMed: | PMC7347339 |
DOI: | 10.1016/j.accpm.2020.07.003 |
PMID: | 32653550 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2352-5568 |
---|---|
DOI: | 10.1016/j.accpm.2020.07.003 |